Age-Related Macular Degeneration Trial

Jerini Ophthalmic’s began in 2007 a Phase I clinical study evaluating JSM 6427 for the treatment of age-related macular degeneration (AMD). The Phase I study will assess the safety of JSM 6427 in patients suffering from AMD, and results from the study are expected in the second half of 2008.